June 9, 2011
The first implant of the Revo MRI™ SureScan® pacing system,
the first MR-Conditional pacing system designed, tested and FDA approved
for use in Magnetic Resonance Imaging (MRI) environment, was recently
completed at Rancho Springs Medical Center. Michael Vargas, MD, Chief of
Cardiology at Rancho Springs Medical Center and Inland Valley Medical
Center, implanted the new device without complication.
"This new device will finally allow pacemaker patients access to MRI scans without any increased risk," Dr. Vargas says. Prior to the Revo MRI SureScan pacing system, MRI procedures for patients with implanted pacemakers were not recommended because these patients might face serious complications, such as interference with pacemaker operation, damage to system components, lead or pacemaker dislodgement or change in pacing capture threshold.
Developed by Medtronic (NYSE: MDT), the Revo MRI SureScan pacing system is the first pacing system of its kind in the U.S. The Revo MRI SureScan pacing system was designed to address safety concerns around MRI procedures for patients who have implanted pacemakers. MRI scanners may cause traditional pacemakers to misinterpret MRI-generated electrical noise and withhold pacing therapy or deliver unnecessary pacing therapy. The Revo MRI pacing system, when programmed into SureScan mode prior to an MRI scan, is designed to be used safely in the MRI environment.
Print Page
